WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004004711) USE OF AT LEAST TWO ANTICANCER COMPOUNDS, ONE OF WHICH AT LEAST MODULATES PROTEASOME ACTIVITY FOR MAKING A MEDICINE FOR CANCER TREATMENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/004711    International Application No.:    PCT/FR2003/002076
Publication Date: 15.01.2004 International Filing Date: 04.07.2003
Chapter 2 Demand Filed:    08.01.2004    
IPC:
A61K 31/427 (2006.01), A61K 31/4375 (2006.01), A61K 31/704 (2006.01)
Applicants: BIOMERIEUX [FR/FR]; F-69280 Marcy-l'Etoile (FR) (For All Designated States Except US).
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE I.N.S.E.R.M. [FR/FR]; 101, rue de Tolbiac, F-75654 Paris Cedex 13 (FR) (For All Designated States Except US).
LOTTEAU, Vincent [FR/FR]; (FR) (For US Only).
ANDRE, Patrice [FR/FR]; (FR) (For US Only).
EVLACHEV, Alexei [RU/FR]; (FR) (For US Only)
Inventors: LOTTEAU, Vincent; (FR).
ANDRE, Patrice; (FR).
EVLACHEV, Alexei; (FR)
Agent: LE CACHEUX, Samuel; Cabinet Beau de Loménie, 51, avenue Jean Jaurès, B.P. 7073, F-69301 Lyon Cedex 07 (FR).
SARLIN, Laure; Cabinet BEAU DE LOMENIE, 51, Avenue Jean Jaurès, B.P. 7073, F-69301 LYON Cedex 07 (FR)
Priority Data:
02/08458 05.07.2002 FR
Title (EN) USE OF AT LEAST TWO ANTICANCER COMPOUNDS, ONE OF WHICH AT LEAST MODULATES PROTEASOME ACTIVITY FOR MAKING A MEDICINE FOR CANCER TREATMENT
(FR) UTILISATION D'AU MOINS DEUX COMPOSES ANTICANCEREUX, DONT UN AU MOINS MODULE L'ACTIVITE DU PROTEASOME POUR LA FABRICATION D'UN MEDICAMENT DESTINE A TRAITER LE CANCER
Abstract: front page image
(EN)The invention concerns the use of at least two anticancer compounds, one of which at least modulates proteasome activity for making a medicine for cancer treatment, in particular colon cancer. The invention also concerns a pharmaceutical composition comprising at least two anticancer compounds, one of which at least modulates proteasome activity in combination with at least one pharmaceutically acceptable carrier.
(FR)La présente invention concerne l'utilisation d'au moins deux composés anticancéreux, dont un au moins module l'activité du protéasome pour la fabrication d'un médicament destiné à traiter le cancer, notamment le cancer du côlon. La présente invention concerne également une composition pharmaceutique comprenant au moins deux composés anticancéreux, dont un au moins module l'activité du protéasome en combinaison avec au moins un excipient pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)